Last mentioned: Mar 6, 2026
JPMorgan Disclosure
JPMorgan Chase & Co. reveals its $12.55 million position in the company.
Insider Activity
CEO Serge Saxonov sells 9,632 shares under a standard trading plan.
Public Disclosure
Institutional filings confirm the acquisition and current valuation of the energy stake.
Syon Capital Entry
Syon Capital LLC discloses a new stake in TXG, adding to institutional support.
Market Momentum
10x Genomics shares trade up 6.4% as market sentiment begins to shift.
Position Initiation
Syon Capital LLC purchases 13,985 shares of Eni SpA during the Q3 reporting period.
JPMorgan Chase & Co. has disclosed a $12.55 million stake in 10x Genomics, signaling institutional confidence in the spatial biology leader. This move comes as the life sciences tools sector navigates a transition toward high-resolution genomic mapping and single-cell analysis.
JPMorgan Chase & Co. has established a significant $12.55 million position in 10x Genomics, signaling institutional confidence in the spatial biology leader. This move comes as the biotech tools sector navigates a complex landscape of patent litigation and shifting R&D budgets.
Syon Capital LLC has established a new stake in Italian energy giant Eni SpA, acquiring nearly 14,000 shares valued at approximately $489,000. This move aligns with a broader trend of institutional investors recalibrating portfolios toward high-yield European energy majors as global energy markets stabilize.